Coiante Scott M 4
4 · Aprea Therapeutics, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to Buy)
2022-07-28+89,200→ 89,200 totalExercise: $1.09Exp: 2032-07-28→ Common Stock (89,200 underlying) - Award
Common Stock
2022-07-28+60,800→ 145,065 total
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock as follows: (i) 20,266 shares on July 28, 2023, (ii) 20,267 shares on July 28, 2024 and (iii) 20,267 shares on July 28, 2025, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Twenty-five percent of these options vest on July 28, 2023, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.